Flora Peyvandi / X
Jun 25, 2025, 15:23
Is the Glanzmann Era Finally Over? Flora Peyvandi on Latest Bispecific Antibodies: ISTH 2025
Flora Peyvandi, Professor of Internal Medicine at the University of Milan and former President of ISTH, shared a post on X:
”How to solve the problem of patients with Glanzmann using a novel bispecific abs – ISTH2025”
So, has the Glanzmann era truly ended—or is it just taking a coffee break before staging a comeback?
Sutacimig, a novel bispecific antibody with dual binding of FVIIa and TLT-1, seems to actually resolve the issues with clot formation in Glanzmann!
More of the latest ISTH2025 news to be posted on Hemostasis Today.
-
Sep 15, 2026, 10:48Ashok Singhal: A Life-Changing Transplant Brings New Hope for Beta Thalassemia
-
Sep 15, 2026, 10:33Vera Ghali: Mitapivat Opens a New Chapter in Thalassemia Treatment
-
Sep 15, 2026, 10:13Behnood Bikdeli: Exploring the Role of Antiphospholipid Antibodies in Ischemic Stroke
-
Sep 15, 2026, 09:55Mark Mamlouk: When Postpartum Headache Signals More Than a CSF Leak
-
Sep 15, 2026, 09:46Nicholas Raccagni: Heparin for VTE Prevention After Traumatic Brain Injury
-
Sep 15, 2026, 09:34Mario D. Caldararo: Are Lines of Zahn Pathognomonic for Antemortem Thrombosis?
-
Sep 15, 2026, 09:24Vishakha K. Kumar: ISTH Is Hiring – Exhibition and Sponsorship Operations Manager
-
Sep 15, 2026, 09:15Mark Mamlouk: The Hidden CSF Leak in Postpartum Headache
-
Sep 15, 2026, 08:59Abdelaziz Fahem: HLH in the GCC – A New Regional Consensus for Diagnosis and Management